<--- Back to Details
First PageDocument Content
Chemistry / Neurochemistry / Morphinans / Opioid antagonists / Clinical medicine / Alcohols / Drug rehabilitation / Ethers / Buprenorphine / Opioid use disorder / Opioid / Naloxone
Date: 2016-06-17 19:41:38
Chemistry
Neurochemistry
Morphinans
Opioid antagonists
Clinical medicine
Alcohols
Drug rehabilitation
Ethers
Buprenorphine
Opioid use disorder
Opioid
Naloxone

Microsoft PowerPoint - SLIDES to USE for AATOD POSTER

Add to Reading List

Source URL: c.eqcdn.com

Download Document from Source Website

File Size: 387,59 KB

Share Document on Facebook

Similar Documents

Neuroendocrinology Letters Volume 33 SupplComparison of gene expression of epicardial and visceral adipocytes with regard to the differentiation stage Institute for Clinical and Experimental Medicine, Departmen

DocID: 1vq9m - View Document

Policy Perspective - A Conversation with Peter Banys, MD, MSc Dr. Peter Banys is a Clinical Professor of Psychiatry at UCSF and Past-President of the California Society of Addiction Medicine. Over a three decade career h

DocID: 1vgR8 - View Document

Responsible Conduct of Research Data Susan Porter Clinical Associate Professor, Department of Pathology & Laboratory Medicine

DocID: 1vcR1 - View Document

1/3 2nd EurOPDX Workshop PDX models in clinical oncology and cancer precision medicine Seminar-Hotel Rigi am See

DocID: 1v75r - View Document

Centre for Cell Therapy and Regenerative Medicine 6th Margaret River Region Forum and 9th ASSCR Annual Scientific Meeting Stem Cells: Fundamental Biology and Clinical Translation

DocID: 1v4Rh - View Document